DK159147C - Analogifremgangsmaade til fremstilling af blandede salte af essentielle eller semi-essentielle aminosyrer og nitrogenfrie analoger heraf - Google Patents
Analogifremgangsmaade til fremstilling af blandede salte af essentielle eller semi-essentielle aminosyrer og nitrogenfrie analoger herafInfo
- Publication number
- DK159147C DK159147C DK163180A DK163180A DK159147C DK 159147 C DK159147 C DK 159147C DK 163180 A DK163180 A DK 163180A DK 163180 A DK163180 A DK 163180A DK 159147 C DK159147 C DK 159147C
- Authority
- DK
- Denmark
- Prior art keywords
- essential
- analogue
- semi
- amino acids
- mixed salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/031,274 US4296127A (en) | 1979-04-18 | 1979-04-18 | Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof |
| US3127479 | 1979-04-18 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK163180A DK163180A (da) | 1980-10-19 |
| DK159147B DK159147B (da) | 1990-09-10 |
| DK159147C true DK159147C (da) | 1991-02-11 |
Family
ID=21858554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK163180A DK159147C (da) | 1979-04-18 | 1980-04-17 | Analogifremgangsmaade til fremstilling af blandede salte af essentielle eller semi-essentielle aminosyrer og nitrogenfrie analoger heraf |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4296127A (de) |
| JP (1) | JPS6024094B2 (de) |
| BE (1) | BE882833A (de) |
| CA (1) | CA1139768A (de) |
| DE (1) | DE3015076A1 (de) |
| DK (1) | DK159147C (de) |
| ES (1) | ES8102804A1 (de) |
| FI (1) | FI70206C (de) |
| FR (1) | FR2454434A1 (de) |
| GB (1) | GB2048867B (de) |
| IE (1) | IE49586B1 (de) |
| IT (1) | IT1141482B (de) |
| LU (1) | LU82369A1 (de) |
| NL (1) | NL191583C (de) |
| NO (1) | NO155239C (de) |
| SE (1) | SE460902B (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61501558A (ja) * | 1984-01-16 | 1986-07-31 | バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテッド | 中および長鎖トリグリセライドの非経口栄養補給 |
| DE3438455A1 (de) * | 1984-10-19 | 1986-06-26 | Institut Dr. Ziegler, Bettingen | L-lysin- und l-histidinpyruvat |
| US4677121A (en) * | 1985-01-22 | 1987-06-30 | The Johns Hopkins University | Method of inhibiting muscle protein degradation |
| US4752619A (en) * | 1985-12-23 | 1988-06-21 | The Johns Hopkins University | Nutritional supplement for treatment of uremia |
| US4744990A (en) * | 1986-09-25 | 1988-05-17 | W. R. Grace & Co. | Hydantoins as animal food supplements |
| US4871552A (en) * | 1986-09-25 | 1989-10-03 | W. R. Grace & Co.-Conn. | Hydantoins as animal food supplements |
| FR2615734B1 (fr) * | 1987-05-27 | 1989-12-01 | Synthelabo | Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie |
| FR2618331B1 (fr) * | 1987-07-23 | 1991-10-04 | Synthelabo | Compositions pharmaceutiques utiles pour le traitement de l'uremie |
| JP2522034B2 (ja) * | 1988-12-27 | 1996-08-07 | 味の素株式会社 | α−ケト酸・アミノ酸塩化合物及びその製造方法 |
| US4957938A (en) * | 1989-06-21 | 1990-09-18 | Abbott Laboratories | Nutritional formulation for the treatment of renal disease |
| DE3936319C3 (de) * | 1989-11-01 | 1997-05-07 | Bartz Volker | Phosphatbinder zur oralen Verabreichung |
| DE3940052A1 (de) * | 1989-12-04 | 1991-06-06 | Nephro Medica Pharma | Dialysier- und spuelloesung zur intraperitonealen verabreichung |
| DE3943424A1 (de) * | 1989-12-30 | 1991-07-04 | Nephro Medica Pharma | Infusions- und injektionsloesung zur intravenoesen verabreichung |
| US5234696A (en) * | 1991-12-27 | 1993-08-10 | Abbott Laboratories | Method of producing tablets, tablets produced thereby, and method of treatment using same |
| US5256697A (en) * | 1992-04-16 | 1993-10-26 | Abbott Laboratories | Method of administering pyruvate and methods of synthesizing pyruvate precursors |
| US5276018A (en) * | 1992-07-17 | 1994-01-04 | Brigham And Women's Hospital | Composition comprising amino acids and methods for decreasing muscle breakdown |
| US20070141181A1 (en) | 1998-02-13 | 2007-06-21 | Nutramax Laboratories, Inc. | Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| US6797289B2 (en) | 1998-02-13 | 2004-09-28 | Nutramax Laboratories, Inc. | Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| US6555141B1 (en) | 1998-02-27 | 2003-04-29 | Nutramax Laboratories, Inc. | L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage |
| US20010000472A1 (en) * | 1998-02-27 | 2001-04-26 | Nutramax Laboratories, Inc. | L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage |
| US8680329B2 (en) * | 2010-10-13 | 2014-03-25 | Tianjin Tiancheng Pharmaceutical Co., Ltd. (China) | Process for preparation of α-ketoglutaric acid |
| US8754256B2 (en) * | 2010-10-13 | 2014-06-17 | Tianjin Tiancheng Pharmaceutical Co., Ltd. (China) | Process for preparation of L-Arginine α-ketoglutarate 1:1 and 2:1 |
| US20140187815A1 (en) * | 2012-12-28 | 2014-07-03 | Guoji Zhang | Process for preparation of l-arginine alpha-ketoglutarate 1:1 and 2:1 |
| CN113677787A (zh) * | 2019-04-11 | 2021-11-19 | 默克专利股份公司 | 包含酮酸的细胞培养基 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2457820A (en) * | 1945-12-27 | 1949-01-04 | Merck & Co Inc | Amino acid solution and process for preparing the same |
| US3441650A (en) * | 1965-07-23 | 1969-04-29 | Lab Jacques Logeais Sa | Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate |
| US3764703A (en) * | 1969-11-07 | 1973-10-09 | Astra Ab | Amino acid mixture for use in treatment of uremic conditions |
| DE2335215B2 (de) * | 1972-07-13 | 1979-04-05 | The Johns Hopkins University, Baltimore, Md. (V.St.A.) | Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen |
| GB1442154A (en) * | 1973-04-30 | 1976-07-07 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body |
| GB1511302A (en) * | 1974-04-15 | 1978-05-17 | Univ Johns Hopkins | Pharmaceutical compositions comprising amino acid analogues |
| US4100293A (en) * | 1974-04-15 | 1978-07-11 | The Johns Hopkins University | Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids |
| FR2315916A2 (fr) * | 1976-03-23 | 1977-01-28 | Univ Johns Hopkins | Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree |
| DE2759133A1 (de) * | 1976-12-31 | 1978-07-13 | Carmelo Prof Giordano | Gemisch essentieller aminosaeuren und/oder analoger ketosaeuren und verwendung derselben diaetzusatz bei niereninsuffizienz |
| US4228099A (en) * | 1978-03-17 | 1980-10-14 | The Johns Hopkins University | Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders |
-
1979
- 1979-04-18 US US06/031,274 patent/US4296127A/en not_active Expired - Lifetime
-
1980
- 1980-04-14 FR FR8008318A patent/FR2454434A1/fr active Granted
- 1980-04-15 JP JP55048770A patent/JPS6024094B2/ja not_active Expired
- 1980-04-17 ES ES490649A patent/ES8102804A1/es not_active Expired
- 1980-04-17 FI FI801225A patent/FI70206C/fi not_active IP Right Cessation
- 1980-04-17 IE IE781/80A patent/IE49586B1/en not_active IP Right Cessation
- 1980-04-17 NO NO801119A patent/NO155239C/no unknown
- 1980-04-17 SE SE8002900A patent/SE460902B/sv not_active IP Right Cessation
- 1980-04-17 DK DK163180A patent/DK159147C/da not_active IP Right Cessation
- 1980-04-17 BE BE0/200266A patent/BE882833A/fr not_active IP Right Cessation
- 1980-04-17 CA CA000350064A patent/CA1139768A/en not_active Expired
- 1980-04-17 LU LU82369A patent/LU82369A1/fr unknown
- 1980-04-18 DE DE19803015076 patent/DE3015076A1/de active Granted
- 1980-04-18 NL NL8002297A patent/NL191583C/xx not_active IP Right Cessation
- 1980-04-18 GB GB8012804A patent/GB2048867B/en not_active Expired
- 1980-04-18 IT IT21498/80A patent/IT1141482B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| NO155239C (no) | 1987-03-04 |
| JPS6024094B2 (ja) | 1985-06-11 |
| IT8021498A0 (it) | 1980-04-18 |
| JPS5653641A (en) | 1981-05-13 |
| SE8002900L (sv) | 1980-12-12 |
| DE3015076A1 (de) | 1980-10-30 |
| SE460902B (sv) | 1989-12-04 |
| FI801225A (fi) | 1980-10-19 |
| NO801119L (no) | 1980-10-20 |
| ES490649A0 (es) | 1981-02-16 |
| CA1139768A (en) | 1983-01-18 |
| GB2048867A (en) | 1980-12-17 |
| NO155239B (no) | 1986-11-24 |
| NL8002297A (nl) | 1980-10-21 |
| IT1141482B (it) | 1986-10-01 |
| GB2048867B (en) | 1983-03-16 |
| FI70206C (fi) | 1986-09-15 |
| IE800781L (en) | 1980-10-19 |
| NL191583C (nl) | 1995-10-03 |
| DK159147B (da) | 1990-09-10 |
| DK163180A (da) | 1980-10-19 |
| BE882833A (fr) | 1980-08-18 |
| FI70206B (fi) | 1986-02-28 |
| US4296127A (en) | 1981-10-20 |
| ES8102804A1 (es) | 1981-02-16 |
| DE3015076C2 (de) | 1988-01-21 |
| FR2454434B1 (de) | 1984-02-24 |
| LU82369A1 (fr) | 1980-07-31 |
| NL191583B (nl) | 1995-06-01 |
| FR2454434A1 (fr) | 1980-11-14 |
| IE49586B1 (en) | 1985-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK159147C (da) | Analogifremgangsmaade til fremstilling af blandede salte af essentielle eller semi-essentielle aminosyrer og nitrogenfrie analoger heraf | |
| DK165455C (da) | Analogifremgangsmaade til fremstilling af dipeptidderivater og farmaceutisk acceptable salte heraf | |
| DK145339C (da) | Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf | |
| DK149594C (da) | Analogifremgangsmaade til fremstilling af dipeptidderivater eller syreadditionssalte heraf | |
| DK164545C (da) | Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf | |
| DK162714C (da) | Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf | |
| DK154654C (da) | Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf | |
| DK148632C (da) | Analogifremgangsmaade til fremstilling af hydroxykarbonylfosfonsyremonoestere eller optiske antipoder og/eller fysiologisk acceptable salte deraf | |
| DK151009C (da) | Analogifremgangsmaade til fremstilling af benzhydrylsulfinylforbindelser og fysiologisk acceptable syreadditionssalte deraf | |
| DK152495C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf | |
| DK143755C (da) | Analogifremgangsmaade til fremstilling af peptidphosphonsyrederivater eller salte deraf | |
| DK153948C (da) | Analogifremgangsmaade til fremstilling af vandoploeselige associationsprodukter af (+)-katekin med en aminosyre og eventuelt tillige en anden syre | |
| DK162444C (da) | Analogifremgangsmaade til fremstilling af azabicyklooctancarboxylsyrer og farmaceutisk acceptable salte heraf | |
| DK31376A (da) | Acetylenderivater af aminosyrer og fremgangsmade til deres fremstilling | |
| AR216638A1 (es) | Mezclas de poliaminas alifaticas guanidadas,o sus sales por adicion de acidos,procedimiento para prepararlas y composiciones para uso agricola que las contienen | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK144127C (da) | Analogifremgangsmaade til fremstilling af lysergsyre- eller 9,10-dihydrolysergsyreamider eller syreadditionssalte deraf | |
| DK143278C (da) | Analogifremgangsmaade til fremstilling af n-(r-tetrahydrofurfuryl)-noroxymorphon eller syreadditionssalte deraf | |
| DK159654C (da) | Analogifremgangsmaade til fremstilling af aminosyrederivater eller fysiologisk acceptable salte deraf | |
| DK151957C (da) | Analogifremgangsmaade til fremstilling af 3-substituerede 2-oxo-1-benzimidazolinalkansyrer eller estere eller amider deraf eller salte deraf med baser | |
| DK149093C (da) | Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf | |
| DK541882A (da) | Fremgangsmaade til fremstilling af n-(vinblastinoyl-23)-derivater af aminosyrer | |
| DK148019C (da) | Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf | |
| DK156068C (da) | Analogifremgangsmaade til fremstilling af n-(2-methoxyethyl)-noroxymorphon eller syreadditionssalte deraf | |
| DK147577C (da) | Analogifremgangsmaade til fremstilling af 2-phenyl-bicyclooctan- eller -octenaminer eller farmaceutisk acceptable syreadditionssalte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed | ||
| PBP | Patent lapsed |